Urine steroid metabolomics as a diagnostic tool in primary aldosteronism (2024)
Attributed to:
Selective CYP11B1 inhibitors as a novel treatment option for endogenous cortisol excess
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.5167/uzh-255578
Publication URI: https://www.zora.uzh.ch/handle/20.500.14742/216188
Type: Journal Article/Review